NCT03501043View on ClinicalTrials.gov

Assessment of Gait After Dysport Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 11, 2018

Primary Completion Date

August 22, 2019

Study Completion Date

August 22, 2019

Conditions
Equinovarus; Acquired
Interventions
DRUG

Dysport

Dysport 1000 to 1500 units to be distributed on the basis of clinical indication to ankle plantar flexors (gastrocnemius and soleus), knee extensors and flexors, tibialis posterior and long toe flexors.

Trial Locations (1)

19002

MossRehab, Elkins Park

All Listed Sponsors
lead

Albert Einstein Healthcare Network

OTHER

NCT03501043 - Assessment of Gait After Dysport Treatment | Biotech Hunter | Biotech Hunter